| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.28 | 7e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |